Variable | No-induction | rATG | Basiliximab | P value |
---|---|---|---|---|
Number | 19 | 24 | 17 | Â |
Gender (M/F) | 9/10 | 16/8 | 9/8 | ns†|
Recipient age (years)* | 57 [27; 70] | 54 [21; 78] | 53 [25; 65] | ns‡ |
Donor age (years)* | 52 [16; 68] | 46 [18; 74] | 61 [21; 75] | <0.05‡a |
HLA MM* | 3 [2; 6] | 3 [1; 5] | 3 [2; 5] | ns‡ |
1st/2nd and 3rd KTx (n) | 19/0 | 11/13§ | 16/1 | <0.0001†|
PRA (%)* | 4 [0; 22] | 68 [0; 96] | 6 [2; 63] | <0.0001‡b |
CNI (TAC/CsA) (n) | 21/4 | 28/0 | 18/0 | ns†|
CIT (hours)* | 16.2 [11.0; 20.7] | 15.4 [7.7; 20.1] | 17.2 [7.7; 21.0] | ns‡ |
Dialysis time (years)* | 2.0 [0.2; 5.7] | 1.9 [0.5; 6.4] | 2.0 [0.6; 4.9] | ns‡ |
Cause of renal failure |  |  |  | ns†|
 Primary GN | 9 | 9 | 4 |  |
 Hereditary diseases | 2 | 5 | 4 |  |
 Diabetic or ischemic nephropathy | 6 | 2 | 7 |  |
 TIN | 2 | 1 | 1 |  |
 ANCA vasculitis or lupus nephritis | 0 | 4 | 0 |  |
 Other causes | 0 | 3 | 1 |  |